Anaemia and fever in kidney transplant. The role of human parvovirus B19

• Published in: Nefrología Vol. 37; no. 2; pp. 206 - 212
• Main Authors: Parodis López, Yanet, Santana Estupiñán, Raquel, Marrero Robayna, Silvia, Gallego Samper, Roberto, Henríquez Palop, Fernando, Rivero Vera, José Carlos, Camacho Galán, Rafael, Pena López, María José, Sablón González, Nery, González Cabrera, Fayna, Oliva Dámaso, Elena, Vega Díaz, Nicanor, Rodríguez Pérez, José Carlos
• Format: Journal Article
• Language: English
• Published: Elsevier 01.03.2017
• Subjects: Human parvovirus B19; Post-transplant anaemia; Renal transplant
• ISSN: 2013-2514; 2013-2514
• DOI: 10.1016/j.nefroe.2017.04.004

Infections remain an issue of particular relevance in renal transplant patients, particularly viral infections. Human parvovirus B19 infection causes severe refractory anaemia, pancytopenia and thrombotic microangiopathy. Its presence is recognised by analysing blood polymerase chain reaction (PCR) and by the discovery of typical giant proerythroblasts in the bone marrow. We report the case of a 65 year-old man with a history of deceased donor renal transplant in September 2014. At 38 days after the transplant, the patient presented progressive anaemia that was resistant to erythropoiesis-stimulating agents. At 64 days after transplant, hyperthermia occurred with progressive deterioration of the patient's general condition. The viral serology and the first blood PCR for human parvovirus B19 were both negative. At 4 months and 19 days after, a bone marrow biopsy was conducted, showing giant erythroblasts with nuclear viral inclusions that were compatible with parvovirus; a PCR in the tissue confirmed the diagnosis. A second blood PCR was positive for parvovirus. After treatment with intravenous immunoglobulin and the temporary discontinuation of mycophenolate mofetil, a complete remission of the disease occurred, although the blood PCR for parvovirus B19 remained positive, so monitoring is necessary for future likely recurrence.